The Regulation and Interactions of the Hypoxia Inducible Factor Pathway in Carcinogenesis and Potential Cancer Therapeutic Strategies — Oak Academic Publishing
Research ArticleOpen AccessGoogle Scholar indexed
The Regulation and Interactions of the Hypoxia Inducible Factor Pathway in Carcinogenesis and Potential Cancer Therapeutic Strategies
Albert Einstein College of Medicine, Jacobi Medical Center, Bronx, NY, USA
,
Albert Einstein College of Medicine, Jacobi Medical Center, Bronx, NY, USA
,
Albert Einstein College of Medicine, Jacobi Medical Center, Bronx, NY, USA
,
Albert Einstein College of Medicine, Jacobi Medical Center, Bronx, NY, USA
,
Albert Einstein College of Medicine, Jacobi Medical Center, Bronx, NY, USA
1 Albert Einstein College of Medicine, Jacobi Medical Center, Bronx, NY, USA
2 Albert Einstein College of Medicine, Jacobi Medical Center, Bronx, NY, USA
3 Albert Einstein College of Medicine, Jacobi Medical Center, Bronx, NY, USA
4 Albert Einstein College of Medicine, Jacobi Medical Center, Bronx, NY, USA
5 Albert Einstein College of Medicine, Jacobi Medical Center, Bronx, NY, USA
The Hypoxia Inducible factor (HIF) pathway is known to be constitutionally active in various cancers and is the dominant pathway in some cancers such as VHL mutant clear cell Renal cell carcinoma. HIF-1 α and HIF-2 α overexpression is known to be important for tumor cell proliferation, maintenance of stemness and angiogenesis. There has been growing interest in therapeutic strategies targeting the HIF pathway over the last decade. We review in this section the role of hypoxia inducible factor pathway in carcinogenesis, its crosstalk with other pathways and potential cancer therapeutic strategies targeting the HIF pathway, its upstream regulators and downstream signaling.
Semenza, G.L. (2013) HIF-1 Mediates Metabolic Responses to Intratumoral Hypoxia and Oncogenic Mutations. The Journal of Clinical Investigation, 123, 3664-3671. http://dx.doi.org/10.1172/JCI67230
Jiang, B.H. and Liu, L.Z. (2008) AKT Signaling in Regulating Angiogenesis. Current Cancer Drug Targets, 8, 19-26. http://dx.doi.org/10.2174/156800908783497122
Joshi, S., Singh, A.R., Zulcic, M. and Durden, D.L. (2014) A Macrophage-Dominant PI3K Isoform Controls Hypoxia-Induced HIF1alpha and HIF2alpha Stability and Tumor Growth, Angiogenesis, and Metastasis. Molecular Cancer Research, 12, 1520-1531. http://dx.doi.org/10.1158/1541-7786.MCR-13-0682
Zhong, H., Chiles, K., Feldser, D., Laughner, E., Hanrahan, C., Georgescu, M.M., et al. (2000) Modulation of Hypoxia-Inducible Factor 1alpha Expression by the Epidermal Growth Factor/Phosphatidylinositol 3-kinase/PTEN/AKT/ FRAP Pathway in human Prostate Cancer Cells: Implications for Tumor Angiogenesis and Therapeutics. Cancer Research, 60, 1541-1545.
Laughner, E., Taghavi, P., Chiles, K., Mahon, P.C. and Semenza, G.L. (2001) HER2 (neu) Signaling Increases the Rate of Hypoxia-Inducible Factor 1alpha (HIF-1alpha) Synthesis: Novel Mechanism for HIF-1-Mediated Vascular Endothelial Growth Factor Expression. Molecular and Cellular Biology, 21, 3995-4004. http://dx.doi.org/10.1128/MCB.21.12.3995-4004.2001
Pore, N., Jiang, Z., Shu, H.K., Bernhard, E., Kao, G.D. and Maity, A. (2006) Akt1 Activation Can Augment Hypoxia-Inducible Factor-1alpha Expression by Increasing Protein Translation through a Mammalian Target of Rapamycin-Independent Pathway. Molecular Cancer Research, 4, 471-479. http://dx.doi.org/10.1158/1541-7786.MCR-05-0234
Li, W., Qiu, T., Zhi, W., Shi, S., Zou, S., Ling, Y., et al. (2015) Colorectal Carcinomas with KRAS Codon 12 Mutation Are Associated with More Advanced Tumor Stages. BMC Cancer, 15, 340. http://dx.doi.org/10.1186/s12885-015-1345-3
Kikuchi, H., Pino, M.S., Zeng, M., Shirasawa, S. and Chung, D.C. (2009) Oncogenic KRAS and BRAF Differentially Regulate Hypoxia-Inducible Factor-1α and -2α in Colon Cancer. Cancer Research, 69, 8499-8506. http://dx.doi.org/10.1158/0008-5472.CAN-09-2213
Kang, R., Hou, W., Zhang, Q., Chen, R., Lee, Y.J., Bartlett, D.L., et al. (2014) RAGE Is Essential for Oncogenic KRAS-Mediated Hypoxic Signaling in Pancreatic Cancer. Cell Death & Disease, 5, e1480. http://dx.doi.org/10.1038/cddis.2014.445
Sun, H.L., Liu, Y.N., Huang, Y.T., Pan, S.L., Huang, D.Y., Guh, J.H., et al. (2007) YC-1 Inhibits HIF-1 Expression in Prostate Cancer Cells: Contribution of Akt/NF-KappaB Signaling to HIF-1Alpha Accumulation during Hypoxia. Oncogene, 26, 3941-3951. http://dx.doi.org/10.1038/sj.onc.1210169
Kondo, K. and Kaelin Jr., W.G. (2001) The von Hippel-Lindau Tumor Suppressor Gene. Experimental Cell Research, 264, 117-125. http://dx.doi.org/10.1006/excr.2000.5139
Haase, V.H. (2006) The VHL/HIF Oxygen-Sensing Pathway and Its Relevance to Kidney Disease. Kidney International, 69, 1302-1307. http://dx.doi.org/10.1038/sj.ki.5000221
Pugh, C.W. and Ratcliffe, P.J. (2003) The von Hippel-Lindau Tumor Suppressor, Hypoxia-Inducible Factor-1 (HIF-1) Degradation, and Cancer Pathogenesis. Seminars in Cancer Biology, 13, 83-89. http://dx.doi.org/10.1016/S1044-579X(02)00103-7
Esteban, M.A., Tran, M.G., Harten, S.K., Hill, P., Castellanos, M.C., Chandra, A., et al. (2006) Regulation of E-Cadherin Expression by VHL and Hypoxia-Inducible Factor. Cancer Research, 66, 3567-3575. http://dx.doi.org/10.1158/0008-5472.CAN-05-2670
Russell, R.C. and Ohh, M. (2007) The Role of VHL in the Regulation of E-Cadherin: A New Connection in an Old Pathway. Cell Cycle, 6, 56-59. http://dx.doi.org/10.4161/cc.6.1.3668
Krishnamachary, B., Zagzag, D., Nagasawa, H., Rainey, K., Okuyama, H., Baek, J.H., et al. (2006) Hypoxia-Inducible Factor-1-Dependent Repression of E-Cadherin in von Hippel-Lindau Tumor Suppressor-Null Renal Cell Carcinoma Mediated by TCF3, ZFHX1A, and ZFHX1B. Cancer Research, 66, 2725-2731. http://dx.doi.org/10.1158/0008-5472.CAN-05-3719
Evans, A.J., Russell, R.C., Roche, O., Burry, T.N., Fish, J.E., Chow, V.W., et al. (2007) VHL Promotes E2 Box-Dependent E-Cadherin Transcription by HIF-Mediated Regulation of SIP1 and Snail. Molecular and Cellular Biology, 27, 157-169. http://dx.doi.org/10.1128/MCB.00892-06
Sermeus, A. and Michiels, C. (2011) Reciprocal Influence of the p53 and the Hypoxic Pathways. Cell Death Disease, 2, e164. http://dx.doi.org/10.1038/cddis.2011.48
Chen, D., Li, M., Luo, J. and Gu, W. (2003) Direct Interactions between HIF-1Alpha and Mdm2 Modulate p53 Function. The Journal of Biological Chemistry, 278, 13595-81359. http://dx.doi.org/10.1074/jbc.C200694200
Hammond, E.M., Mandell, D.J., Salim, A., Krieg, A.J., Johnson, T.M., Shirazi, H.A., et al. (2006) Genome-Wide Analysis of p53 under Hypoxic Conditions. Molecular and Cellular Biology, 26, 3492-3504. http://dx.doi.org/10.1128/MCB.26.9.3492-3504.2006
Ravi, R., Mookerjee, B., Bhujwalla, Z.M., Sutter, C.H., Artemov, D., Zeng, Q., et al. (2000) Regulation of Tumor Angiogenesis by p53-Induced Degradation of Hypoxia-Inducible Factor 1Alpha. Genes Development, 14, 34-44.
Sumiyoshi, Y., Kakeji, Y., Egashira, A., Mizokami, K., Orita, H. and Maehara, Y. (2006) Overexpression of Hypoxia-Inducible Factor 1Alpha and p53 Is a Marker for an Unfavorable Prognosis in Gastric Cancer. Clinical Cancer Research, 12, 5112-5117. http://dx.doi.org/10.1158/1078-0432.CCR-05-2382
Kamat, C.D., Green, D.E., Warnke, L., Thorpe, J.E., Ceriello, A. and Ihnat, M.A. (2007) Mutant p53 Facilitates Pro-Angiogenic, Hyperproliferative Phenotype in Response to Chronic Relative Hypoxia. Cancer Letters, 249, 209-219. http://dx.doi.org/10.1016/j.canlet.2006.08.017
Xu, Y., Li, Y., Pang, Y., Ling, M., Shen, L., Yang, X., et al. (2012) EMT and Stem Cell-Like Properties Associated with HIF-2Alpha Are Involved in Arsenite-Induced Transformation of Human Bronchial Epithelial Cells. PLoS ONE, 7, e37765. http://dx.doi.org/10.1371/journal.pone.0037765
Higgins, D.F., Kimura, K., Bernhardt, W.M., Shrimanker, N., Akai, Y., Hohenstein, B., et al. (2007) Hypoxia Promotes Fibrogenesis in Vivo via HIF-1 Stimulation of Epithelial-to-Mesenchymal Transition. The Journal of Clinical Investigation, 117, 3810-3820. http://dx.doi.org/10.1172/jci30487
Mimeault, M. and Batra, S.K. (2013) Hypoxia-Inducing Factors as Master Regulators of Stemness Properties and Altered Metabolism of Cancer- and Metastasis-Initiating Cells. Journal of Cellular and Molecular Medicine, 17, 30-54. http://dx.doi.org/10.1111/jcmm.12004
Du, R., Xia, L., Ning, X., Liu, L., Sun, W., Huang, C., et al. (2014) Hypoxia-Induced Bmi1 Promotes Renal Tubular Epithelial Cell-Mesenchymal Transition and Renal Fibrosis via PI3K/Akt Signal. Molecular Biology of the Cell, 25, 2650-2659. http://dx.doi.org/10.1091/mbc.E14-01-0044
Guo, B.H., Feng, Y., Zhang, R., Xu, L.H., Li, M.Z., Kung, H.F., et al. (2011) Bmi-1 Promotes Invasion and Metastasis, and Its Elevated Expression Is Correlated with an Advanced Stage of Breast Cancer. Molecular Cancer, 10, 10. http://dx.doi.org/10.1186/1476-4598-10-10
Yang, M.H., Hsu, D.S., Wang, H.W., Wang, H.J., Lan, H.Y., Yang, W.H., et al. (2010) Bmi1 Is Essential in Twist1-Induced Epithelial-Mesenchymal Transition. Nature Cell Biology, 12, 982-992. http://dx.doi.org/10.1038/ncb2099
Song, L.B., Li, J., Liao, W.T., Feng, Y., Yu, C.P., Hu, L.J., et al. (2009) The Polycomb Group Protein Bmi-1 Represses the Tumor Suppressor PTEN and Induces Epithelial-Mesenchymal Transition in Human Nasopharyngeal Epithelial Cells. The Journal of Clinical Investigation, 119, 3626-3636. http://dx.doi.org/10.1172/JCI39374
Sun, S., Ning, X., Zhang, Y., Lu, Y., Nie, Y., Han, S., et al. (2009) Hypoxia-Inducible Factor-1alpha Induces Twist Expression in Tubular Epithelial Cells Subjected to Hypoxia, Leading to Epithelial-to-Mesenchymal Transition. Kidney International, 75, 1278-1287. http://dx.doi.org/10.1038/ki.2009.62
Chang, L.H., Chen, C.H., Huang, D.Y., Pai, H.C., Pan, S.L. and Teng, C.M. (2011) Thrombin Induces Expression of Twist and Cell Motility via the Hypoxia-Inducible Factor-1Alpha Translational Pathway in Colorectal Cancer Cells. Journal of Cellular Physiology, 226, 1060-1068. http://dx.doi.org/10.1002/jcp.22428
Wu, C.Y., Hung, J.J. and Wu, K.J. (2012) Linkage between Twist1 and Bmi1: Molecular Mechanism of Cancer Metastasis/Stemness and Clinical Implications. Clinical and Experimental Pharmacology and Physiology, 39, 668-673. http://dx.doi.org/10.1111/j.1440-1681.2011.05594.x
Wu, K.J. and Yang, M.H. (2011) Epithelial-Mesenchymal Transition and Cancer Stemness: The Twist1-Bmi1 Connection. Bioscience Reports, 31, 449-455. http://dx.doi.org/10.1042/BSR20100114
Wu, K.J. (2011) Direct Activation of Bmi1 by Twist1: Implications in Cancer Stemness, Epithelial-Mesenchymal Transition, and Clinical Significance. Chang Gung Medical Journal, 34, 229-238.
Liu, S., Dontu, G., Mantle, I.D., Patel, S., Ahn, N.S., Jackson, K.W., et al. (2006) Hedgehog Signaling and Bmi-1 Regulate Self-Renewal of Normal and Malignant Human Mammary Stem Cells. Cancer Research, 66, 6063-6071. http://dx.doi.org/10.1158/0008-5472.CAN-06-0054
Copple, B.L. (2010) Hypoxia Stimulates Hepatocyte Epithelial to Mesenchymal Transition by Hypoxia-Inducible Factor and Transforming Growth Factor-Beta-Dependent Mechanisms. Liver International, 30, 669-682. http://dx.doi.org/10.1111/j.1478-3231.2010.02205.x
Han, W.Q., Zhu, Q., Hu, J., Li, P.L., Zhang, F. and Li, N. (2013) Hypoxia-Inducible Factor Prolyl-Hydroxylase-2 Mediates Transforming Growth Factor Beta1-Induced Epithelial-Mesenchymal Transition in Renal Tubular Cells. Biochimica et Biophysica Acta, 1833, 1454-1462. http://dx.doi.org/10.1016/j.bbamcr.2013.02.029
Basu, R.K., Hubchak, S., Hayashida, T., Runyan, C.E., Schumacker, P.T. and Schnaper, H.W. (2011) Interdependence of HIF-1Alpha and TGF-Beta/Smad3 Signaling in Normoxic and Hypoxic Renal Epithelial Cell Collagen Expression. Renal Physiology—American Journal of Physiology, 300, F898-F905. http://dx.doi.org/10.1152/ajprenal.00335.2010
Bai, H., Ge, S., Lu, J., Qian, G. and Xu, R. (2013) Hypoxia Inducible Factor-1Alpha-Mediated Activation of Survivin in Cervical Cancer Cells. Journal of Obstetrics and Gynaecology Research, 39, 555-563. http://dx.doi.org/10.1111/j.1447-0756.2012.01995.x
Peng, X.H., Karna, P., Cao, Z., Jiang, B.H., Zhou, M. and Yang, L. (2006) Cross-Talk between Epidermal Growth Factor Receptor and Hypoxia-Inducible Factor-1Alpha Signal Pathways Increases Resistance to Apoptosis by Up-Regulating Survivin Gene Expression. The Journal of Biological Chemistry, 281, 25903-25914. http://dx.doi.org/10.1074/jbc.M603414200
Wang, Y.F., Ma, S.R., Wang, W.M., Huang, C.F., Zhao, Z.L., Liu, B., et al. (2014) Inhibition of Survivin Reduces HIF-1Alpha, TGF-Beta1 and TFE3 in Salivary Adenoid Cystic Carcinoma. PLoS ONE, 9, e114051. http://dx.doi.org/10.1371/journal.pone.0114051
Chen, S., Zhang, M., Xing, L., Wang, Y., Xiao, Y. and Wu, Y. (2015) HIF-1Alpha Contributes to Proliferation and Invasiveness of Neuroblastoma Cells via SHH Signaling. PLoS ONE, 10, e0121115. http://dx.doi.org/10.1371/journal.pone.0121115
Onishi, H., Morisaki, T., Nakao, F., Odate, S., Morisaki, T. and Katano, M. (2013) Protein-Bound Polysaccharide Decreases Invasiveness and Proliferation in Pancreatic Cancer by Inhibition of Hedgehog Signaling and HIF-1Alpha Pathways under Hypoxia. Cancer Letters, 335, 289-298. http://dx.doi.org/10.1016/j.canlet.2013.02.041
Lei, J., Ma, J., Ma, Q., Li, X., Liu, H., Xu, Q., et al. (2013) Hedgehog Signaling Regulates Hypoxia Induced Epithelial to Mesenchymal Transition and Invasion in Pancreatic Cancer Cells via a Ligand-Independent Manner. Molecular Cancer, 12, 66. http://dx.doi.org/10.1186/1476-4598-12-66
Cejudo-Martin, P. and Johnson, R.S. (2005) A New Notch in the HIF Belt: How Hypoxia Impacts Differentiation. Developmental Cell, 9, 575-576. http://dx.doi.org/10.1016/j.devcel.2005.10.001
Irshad, K., Mohapatra, S.K., Srivastava, C., Garg, H., Mishra, S., Dikshit, B., et al. (2015) A Combined Gene Signature of Hypoxia and Notch Pathway in Human Glioblastoma and Its Prognostic Relevance. PLoS ONE, 10, e0118201. http://dx.doi.org/10.1371/journal.pone.0118201
Gustafsson, M.V., Zheng, X., Pereira, T., Gradin, K., Jin, S., Lundkvist, J., et al. (2005) Hypoxia Requires Notch Signaling to Maintain the Undifferentiated Cell State. Developmental Cell, 9, 617-628. http://dx.doi.org/10.1016/j.devcel.2005.09.010
Diez, H., Fischer, A., Winkler, A., Hu, C.J., Hatzopoulos, A.K., Breier, G., et al. (2007) Hypoxia-Mediated Activation of Dll4-Notch-Hey2 Signaling in Endothelial Progenitor Cells and Adoption of Arterial Cell Fate. Experimental Cell Research, 313, 1-9. http://dx.doi.org/10.1016/j.yexcr.2006.09.009
Zheng, X., Linke, S., Dias, J.M., Zheng, X., Gradin, K., Wallis, T.P., et al. (2008) Interaction with Factor Inhibiting HIF-1 Defines an Additional Mode of Cross-Coupling between the Notch and Hypoxia Signaling Pathways. Proceedings of the National Academy of Sciences of the United States of America, 105, 3368-3373. http://dx.doi.org/10.1073/pnas.0711591105
Ohh, M. (2012) Tumor Strengths and Frailties: Cancer SUMmOns Otto’s Metabolism. Nature Medicine, 18, 30-31. http://dx.doi.org/10.1038/nm.2631
Busca, R., Berra, E., Gaggioli, C., Khaled, M., Bille, K., Marchetti, B., et al. (2005) Hypoxia-Inducible Factor 1Alpha Is a New Target of Microphthalmia-Associated Transcription Factor (MITF) in Melanoma Cells. The Journal of Cell Biology, 170, 49-59. http://dx.doi.org/10.1083/jcb.200501067
Panneerselvam, J., Jin, J., Shanker, M., Lauderdale, J., Bates, J., Wang, Q., et al. (2015) IL-24 Inhibits Lung Cancer Cell Migration and Invasion by Disrupting The SDF-1/CXCR4 Signaling Axis. PLoS ONE, 10, e0122439. http://dx.doi.org/10.1371/journal.pone.0122439
Mori, T., Doi, R., Koizumi, M., Toyoda, E., Ito, D., Kami, K., et al. (2004) CXCR4 Antagonist Inhibits Stromal Cell-Derived Factor 1-Induced Migration and Invasion of Human Pancreatic Cancer. Molecular Cancer Therapeutics, 3, 29-37. http://dx.doi.org/10.1186/1476-4598-3-29
Wu, H., Zhu, L., Zhang, H., Shi, X., Zhang, L., Wang, W., et al. (2015) Coexpression of EGFR and CXCR4 Predicts Poor Prognosis in Resected Pancreatic Ductal Adenocarcinoma. PLoS ONE, 10, e0116803. http://dx.doi.org/10.1371/journal.pone.0116803
Phillips, R.J., Mestas, J., Gharaee-Kermani, M., Burdick, M.D., Sica, A., Belperio, J.A., et al. (2005) Epidermal Growth Factor and Hypoxia-Induced Expression of CXC Chemokine Receptor 4 on Non-Small Cell Lung Cancer Cells Is Regulated by the Phosphatidylinositol 3-Kinase/PTEN/AKT/Mammalian Target of Rapamycin Signaling Pathway and Activation of Hypoxia Inducible Factor-1Alpha. The Journal of Biological Chemistry, 280, 22473-22481. http://dx.doi.org/10.1074/jbc.M500963200
Wilson, J.L., Burchell, J. and Grimshaw, M.J. (2006) Endothelins Induce CCR7 Expression by Breast Tumor Cells via Endothelin Receptor A and Hypoxia-Inducible Factor-1. Cancer Research, 66, 11802-11807. http://dx.doi.org/10.1158/0008-5472.CAN-06-1222
Semenza, G.L. (2010) HIF-1: Upstream and Downstream of Cancer Metabolism. Current Opinion in Genetics Development, 20, 51-56. http://dx.doi.org/10.1016/j.gde.2009.10.009
Courtnay, R., Ngo, D.C., Malik, N., Ververis, K., Tortorella, S.M. and Karagiannis, T.C. (2015) Cancer Metabolism and the Warburg Effect: The Role of HIF-1 and PI3K. Molecular Biology Reports, 42, 841-851. http://dx.doi.org/10.1007/s11033-015-3858-x
Iyer, N.V., Kotch, L.E., Agani, F., Leung, S.W., Laughner, E., Wenger, R.H., et al. (1998) Cellular and Developmental Control of O2 Homeostasis by Hypoxia-Inducible Factor 1Alpha. Genes Development, 12, 149-162. http://dx.doi.org/10.1101/gad.12.2.149
Chen, C., Pore, N., Behrooz, A., Ismail-Beigi, F. and Maity, A. (2001) Regulation of glut1 mRNA by Hypoxia-Inducible Factor-1. Interaction between H-ras and Hypoxia. The Journal of Biological Chemistry, 276, 9519-9525. http://dx.doi.org/10.1074/jbc.M010144200
Sadlecki, P., Bodnar, M., Grabiec, M., Marszalek, A., Walentowicz, P., Sokup, A., et al. (2014) The Role of Hypoxia-Inducible Factor-1α, Glucose Transporter-1, (GLUT-1) and Carbon Anhydrase IX in Endometrial Cancer Patients. BioMed Research International, 2014, Article ID: 616850.
Ullah, M.S., Davies, A.J. and Halestrap, A.P. (2006) The Plasma Membrane Lactate Transporter MCT4, but Not MCT1, Is Up-Regulated by Hypoxia through a HIF-1Alpha-Dependent Mechanism. The Journal of Biological Chemistry, 281, 9030-9037. http://dx.doi.org/10.1074/jbc.M511397200
Vander Heiden, M.G., Cantley, L.C. and Thompson, C.B. (2009) Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation. Science, 324, 1029-1033. http://dx.doi.org/10.1126/science.1160809
Kim, J.W., Gao, P., Liu, Y.C., Semenza, G.L. and Dang, C.V. (2007) Hypoxia-Inducible Factor 1 and Dysregulated c-Myc Cooperatively Induce Vascular Endothelial Growth Factor and Metabolic Switches Hexokinase 2 and Pyruvate Dehydrogenase Kinase 1. Molecular and Cellular Biology, 27, 7381-7393. http://dx.doi.org/10.1128/MCB.00440-07
Kim, J.W., Tchernyshyov, I., Semenza, G.L. and Dang, C.V. (2006) HIF-1-Mediated Expression of Pyruvate Dehydrogenase Kinase: A Metabolic Switch Required for Cellular Adaptation to Hypoxia. Cell Metabolism, 3, 177-185. http://dx.doi.org/10.1016/j.cmet.2006.02.002
Dang, C.V. (2007) The Interplay between MYC and HIF in the Warburg Effect. Ernst Schering Foundation Symposium Proceedings, 2007, 35-53.
Yeung, S.J., Pan, J. and Lee, M.H. (2008) Roles of p53, MYC and HIF-1 in Regulating Glycolysis—The Seventh Hallmark of Cancer. Cellular and Molecular Life Sciences, 65, 3981-3999. http://dx.doi.org/10.1007/s00018-008-8224-x
Hu, C.Y., Mohtat, D., Yu, Y., Ko, Y.A., Shenoy, N., Bhattacharya, S., et al. (2014) Kidney Cancer Is Characterized by Aberrant Methylation of Tissue-Specific Enhancers That Are Prognostic for Overall Survival. Clinical Cancer Research, 20, 4349-4360. http://dx.doi.org/10.1158/1078-0432.CCR-14-0494
Fath, D.M., Kong, X., Liang, D., Lin, Z., Chou, A., Jiang, Y., et al. (2006) Histone Deacetylase Inhibitors Repress the Transactivation Potential of Hypoxia-Inducible Factors Independently of Direct Acetylation of HIF-Alpha. The Journal of Biological Chemistry, 281, 13612-13619. http://dx.doi.org/10.1074/jbc.M600456200
Burroughs, S.K., Kaluz, S., Wang, D., Wang, K., Van Meir, E.G. and Wang, B. (2013) Hypoxia Inducible Factor Pathway Inhibitors as Anticancer Therapeutics. Future Medicinal Chemistry, 5, 553-572. http://dx.doi.org/10.4155/fmc.13.17
Chau, N.M., Rogers, P., Aherne, W., Carroll, V., Collins, I., McDonald, E., et al. (2005) Identification of Novel Small Molecule Inhibitors of Hypoxia-Inducible Factor-1 That Differentially Block Hypoxia-Inducible Factor-1 Activity and Hypoxia-Inducible Factor-1Alpha Induction in Response to Hypoxic Stress and Growth Factors. Cancer Research, 65, 4918-4928. http://dx.doi.org/10.1158/0008-5472.CAN-04-4453
Tan, C., de Noronha, R.G., Roecker, A.J., Pyrzynska, B., Khwaja, F., Zhang, Z., et al. (2005) Identification of a Novel Small-Molecule Inhibitor of the Hypoxia-Inducible Factor 1 Pathway. Cancer Research, 65, 605-612.
Welsh, S.J., Dale, A.G., Lombardo, C.M., Valentine, H., de la Fuente, M., Schatzlein, A., et al. (2013) Inhibition of the Hypoxia-Inducible Factor Pathway by a G-Quadruplex Binding Small Molecule. Scientific Reports, 3, Article No. 2799. http://dx.doi.org/10.1038/srep02799
Bertout, J.A., Majmundar, A.J., Gordan, J.D., Lam, J.C., Ditsworth, D., Keith, B., et al. (2009) HIF2Alpha Inhibition Promotes p53 Pathway Activity, Tumor Cell Death, and Radiation Responses. Proceedings of the National Academy of Sciences of the United States of America, 106, 14391-14396. http://dx.doi.org/10.1073/pnas.0907357106
Scheuermann, T.H., Li, Q., Ma, H.W., Key, J., Zhang, L., Chen, R., et al. (2013) Allosteric Inhibition of Hypoxia Inducible Factor-2 with Small Molecules. Nature Chemical Biology, 9, 271-276. http://dx.doi.org/10.1038/nchembio.1185
Allison, S.J., Knight, J.R., Granchi, C., Rani, R., Minutolo, F., Milner, J., et al. (2014) Identification of LDH-A as a Therapeutic Target for Cancer Cell Killing via (i) p53/NAD(H)-Dependent and (ii) p53-Independent Pathways. Oncogenesis, 3, e102. http://dx.doi.org/10.1038/oncsis.2014.16
Doherty, J.R. and Cleveland, J.L. (2013) Targeting Lactate Metabolism for Cancer Therapeutics. The Journal of Clinical Investigation, 123, 3685-3692. http://dx.doi.org/10.1172/JCI69741
Kuiper, C., Molenaar, I.G., Dachs, G.U., Currie, M.J., Sykes, P.H. and Vissers, M.C. (2010) Low Ascorbate Levels Are Associated with Increased Hypoxia-Inducible Factor-1 Activity and an Aggressive Tumor Phenotype in Endometrial Cancer. Cancer Research, 70, 5749-5758. http://dx.doi.org/10.1158/0008-5472.CAN-10-0263
Flashman, E., Davies, S.L., Yeoh, K.K., Schofield, C.J. (2010) Investigating the Dependence of the Hypoxia-Inducible Factor Hydroxylases (Factor Inhibiting HIF and Prolyl Hydroxylase Domain 2) on Ascorbate and Other Reducing Agents. The Biochemical Journal, 427, 135-142. http://dx.doi.org/10.1042/BJ20091609
Tian, W., Wang, Y., Xu, Y., Guo, X., Wang, B., Sun, L., et al. (2014) The Hypoxia-Inducible Factor Renders Cancer Cells More Sensitive to Vitamin C-Induced Toxicity. The Journal of Biological Chemistry, 289, 3339-3351. http://dx.doi.org/10.1074/jbc.M113.538157
Chen, .J, Zhao, S., Nakada, K., Kuge, Y., Tamaki, N., Okada, F., et al. (2003) Dominant-Negative Hypoxia-Inducible Factor-1Alpha Reduces Tumorigenicity of Pancreatic Cancer Cells through the Suppression of Glucose Metabolism. The American Journal of Pathology, 162, 1283-1291. http://dx.doi.org/10.1016/S0002-9440(10)63924-7
Padayatty, S.J., Riordan, H.D., Hewitt, S.M., Katz, A., Hoffer, L.J. and Levine, M. (2006) Intravenously Administered Vitamin C as Cancer Therapy: Three Cases. CMAJ: Canadian Medical Association Journal, 174, 937-942. http://dx.doi.org/10.1503/cmaj.050346
Rapisarda, A., Uranchimeg, B., Sordet, O., Pommier, Y., Shoemaker, R.H. and Melillo, G. (2004) Topoisomerase I-Mediated Inhibition of Hypoxia-Inducible Factor 1: Mechanism and Therapeutic Implications. Cancer Research, 64, 1475-1482. http://dx.doi.org/10.1158/0008-5472.CAN-03-3139
Lou, J.J., Chua, Y.L., Chew, E.H., Gao, J., Bushell, M. and Hagen, T. (2010) Inhibition of Hypoxia-Inducible Factor-1Alpha (HIF-1Alpha) Protein Synthesis by DNA Damage Inducing Agents. PLoS ONE, 5, e10522. http://dx.doi.org/10.1371/journal.pone.0010522
Shin, D.H., Chun, Y.S., Lee, D.S., Huang, L.E. and Park, J.W. (2008) Bortezomib Inhibits Tumor Adaptation to Hypoxia by Stimulating the FIH-Mediated Repression of Hypoxia-Inducible Factor-1. Blood, 111, 3131-3136. http://dx.doi.org/10.1182/blood-2007-11-120576
Thomas, G.V., Tran, C., Mellinghoff, I.K., Welsbie, D.S., Chan, E., Fueger, B., et al. (2006) Hypoxia-Inducible Factor Determines Sensitivity to Inhibitors of mTOR in Kidney Cancer. Nature Medicine, 12, 122-127. http://dx.doi.org/10.1038/nm1337
Kondapaka, S.B., Singh, S.S., Dasmahapatra, G.P., Sausville, E.A. and Roy, K.K. (2003) Perifosine, a Novel Alkylphospholipid, Inhibits Protein Kinase B Activation. Molecular Cancer Therapeutics, 2, 1093-1103.
Jayatunga, M.K., Thompson, S., McKee, T.C., Chan, M.C., Reece, K.M., Hardy, A.P., et al. (2015) Inhibition of the HIF1Alpha-p300 Interaction by Quinone- and Indandione-Mediated Ejection of Structural Zn(II). European Journal of Medicinal Chemistry, 94, 509-516. http://dx.doi.org/10.1016/j.ejmech.2014.06.006
Wu, D., Zhang, R., Zhao, R., Chen, G., Cai, Y. and Jin, J. (2013) A Novel Function of Novobiocin: Disrupting the Interaction of HIF 1Alpha and p300/CBP through Direct Binding to the HIF1Alpha C-Terminal Activation Domain. PLoS ONE, 8, e62014. http://dx.doi.org/10.1371/journal.pone.0062014
Cook, K.M., Hilton, S.T., Mecinovic, J., Motherwell, W.B., Figg, W.D. and Schofield, C.J. (2009) Epidithiodiketopiperazines Block the Interaction between Hypoxia-Inducible Factor-1Alpha (HIF-1Alpha) and p300 by a Zinc Ejection Mechanism. The Journal of Biological Chemistry, 284, 26831-26838. http://dx.doi.org/10.1074/jbc.M109.009498